Evidence map›Paper›PMID 33502585›Full record

ArticleMikrochimica acta2021

Colorimetric determination of amyloid-β peptide using MOF-derived nanozyme based on porous ZnO-Co

Xi Zhou, Shuangling Wang, Cong Zhang, Yulong Lin, Jie Lv, Shuyang Hu, Shanshan Zhang, Meng Li

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Progress in ZnO Nanosensors.Sensors (Basel, Switzerland) · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xi Zhou *College of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Shuangling Wang *College of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Cong ZhangDepartment of Chemistry, School of Sciences, Hebei University of Science and Technology, Shijiazhuang, 050018, China. zhangcong0672@163.com.ORCID 0000-0002-8348-6768
Yulong LinCollege of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Jie LvCollege of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Shuyang HuCollege of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Shanshan ZhangCollege of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China.
Meng LiCollege of Pharmacy, Hebei Medical University, Shijiazhuang, 050017, China. limeng87@hotmail.com.
Hebei Medical University · CNHebei University of Science and Technology · CN

Funding

National Natural Science Foundation of China 21807024
6 · The paper itself

Abstract

A sensitive and rapid colorimetric biosensor has been developed for determination of amyloid-β peptide (Aβ) and study of amyloidogenesis based on the high peroxidase-like activity of porous bimetallic ZnO-Co

Indexed as

Amyloid beta-PeptidesAnimalsBenzidinesCatalysisChromogenic CompoundsCobaltColorimetryLimit of DetectionMetal-Organic FrameworksOxidesPeptide FragmentsPorosityRatsZinc Oxide3,3',5,5'-tetramethylbenzidineAmyloid beta-Peptidesamyloid beta-protein (1-40)BenzidinesChromogenic CompoundsCobaltcobalt oxideMetal-Organic FrameworksOxidesPeptide FragmentsZinc OxideAlzheimer’s diseaseAmyloidogenesis studyAmyloid-β peptideInhibitor screeningPeroxidase-like activityPorous ZnO-Co3O4 nanocages

Identifiers

PMID33502585
OpenAlexW3125188771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.